aTYR PHARMA INC (LIFE) Operating Lease, Right-of-Use Asset USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
aTYR PHARMA INC quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2018 to 2024.
  • aTYR PHARMA INC Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $6 M, a 13.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $6 M -$943 K -13.6% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $6.73 M -$523 K -7.21% Dec 31, 2023 10-Q 2024-05-02
Q3 2023 $6.81 M -$159 K -2.28% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $7.12 M +$6.29 M +761% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $6.94 M +$5.89 M +561% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $7.25 M +$5.98 M +472% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $6.97 M +$5.49 M +371% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $827 K -$858 K -50.9% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.05 M -$836 K -44.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.27 M -$816 K -39.2% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $1.48 M -$795 K -35% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.69 M -$776 K -31.5% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $1.89 M -$757 K -28.6% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $2.08 M -$738 K -26.2% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $2.27 M -$720 K -24% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $2.46 M -$703 K -22.2% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $2.64 M -$680 K -20.5% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $2.82 M -$679 K -19.4% Dec 31, 2019 10-K 2021-03-24
Q3 2019 $2.99 M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $3.16 M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $3.32 M Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $3.5 M Jan 1, 2019 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.